Neumora Therapeutics, Inc. Common Stock
$0.47
+0.05 (+10.96%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- -36.8%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -79.5%
Own NMRA?
See how NMRA contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.